Previous Page  3 / 10 Next Page
Information
Show Menu
Previous Page 3 / 10 Next Page
Page Background

Page 13

Notes:

J Pharmacol Ther Res 2017 Volume 1 Issue 2

allied

academies

November 02-03, 2017 Chicago, USA

4

th

International Congress on

International Conference and Exhibition on

Drug Discovery, Designing and Development

Biochemistry, Molecular Biology: R&D

&

C

ollaborative Drug Discovery (CDD) provides trailing

innovation for today’s chemical and biological data needs,

differentiated by ease-of-use and superior collaborative

data sharing workflows. Within the CDD vault software,

activity and registration, visualization, inventory, and ELN

capabilities all address today’s markets. Secure, web-based

collaborative technologies are especially applicable to the

informatics needs of (and broadly used by) public-private-

partnerships (PPPs). Web-based platforms are a natural fit

for collaboration due to the economic, architectural, and

design benefits of a single platform that transcends any one

organization’s solo requirements. In contrast to the CDD vault

for today’s collaborations, CDD’s Research Informatics Group

invents bleeding edge technologies for tomorrow’s needs.

For example, open source descriptors and model sharing

capabilities allow for platform-independent collaborations,

even for sensitive data and IP, with groups reticent to share.

CDD and Pfizer have demonstrated that these open source

descriptors and models were statistically like commercial

models. The main idea is to democratize model building

to engage experimentalists to want to use models. As

a second example, the recently developed BioAssay

Express (BAE) technology streamlines the conversion of

human-readable assay descriptions to computer-readable

information Tanimoto (Jaccard) chemical and biological

sequence similarity searches. BAE uses. Here the main idea

is to allow researchers to easily search and combine similar

bioassay protocols, even though those similarity searches

are much more difficult than semantic standards to markup

bioprotocols, which unleashes the full power of informatics

technology on data that could previously only be organized

by crude text searching

(https://peerj.com/articles/cs-

61/). These two newer web-technologies may be used not

only with the CDD Vault, but also with other commercial,

academic, or government built software tools. All open

source components are in GitHub.

Speaker Biography

Luke’s background brings twenty years of experience in scientific informatics solutions.

Managing Pre-Sales, Post-Sales and working in Account Management has expanded his

domain knowledge of scientific informatics and provided him the ability to maintain

a successful track record. Luke serves leading pharmaceutical, biotech, agricultural,

chemicals, academic and government labs. Luke has experience in scientific software

solutions from the smaller scale deployment of point solutions like molecular modeling

packages to the larger enterprise scale of ELNs, scientific workflow technologies,

data content, analysis and visualization. His background also includes managing the

support complexity of software integration strategies based on numerous mergers and

acquisitions.

e:

luke@collaborativedrug.com

Luke S Fisher

Collaborative Drug Discovery, USA

Drug discovery informatics for collaborative teams: Innovations available today

and planned for tomorrow